E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Announces Publication of Study on the Effect of non-invasive Vagus Nerve Stimulation (nVNS) on Cognitive Performance Caused by Sleep Deprivation
June 24, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, June 24, 2021 (GLOBE NEWSWIRE) --  electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a peer-reviewed paper on...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore, Inc. Announces Exclusive Distribution Agreement with Kromax For Taiwan and China
June 23, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, June 23, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced it has entered into an agreement with Kromax...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore to Join Russell Microcap® Index
June 16, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, June 16, 2021 (GLOBE NEWSWIRE) --  electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced today the addition of its stock to the broad-market...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore Completes Sale of $1.4 Million of NJ NOL Tax Benefits 
June 09, 2021 08:00 ET | electroCore, Inc.
ROCKAWAY, NJ, June 09, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has completed the sale of $1.4 million of...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International to Present at LD Micro Virtual Investor Conference 
June 08, 2021 07:00 ET | Odyssey Group International
IRVINE, CA, June 08, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Announces Successful Completion of Their Novel Nano-Particle Drug Formulation for Treating Concussion
June 02, 2021 07:30 ET | Odyssey Group International
Irvine, CA, June 02, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...
E81DACBA-F17B-416E-96AA-C61EE583520F.png
electroCore to Present at Investor Conferences in June
May 26, 2021 07:30 ET | electroCore, Inc.
ROCKAWAY, NJ, May 26, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, announced today that its management team will present a several...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Announces Successful Toxicology Studies for its Concussion Drug
May 26, 2021 07:29 ET | Odyssey Group International
IRVINE, CA, May 26, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International, Inc. Schedules Annual Meeting of Stockholders
May 24, 2021 08:00 ET | Odyssey Group International
IRVINE, CA, May 24, 2021 (GLOBE NEWSWIRE) -- – Odyssey Group International, Inc. (OTCQB: ODYY) ("ODYY" or "the Company"), Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"),...
A743C747-1A0E-411A-BE19-027558A02AB3.png
Odyssey Group International Announces Completion of Novel Device for Nasal Delivery of Concussion Drug Candidate
May 19, 2021 08:00 ET | Odyssey Group International
IRVINE, CA, May 19, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique,...